Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study (2021)
- Authors:
- Autor USP: RODRIGUES, RODRIGO DO TOCANTINS CALADO DE SALOMA - FMRP
- Unidade: FMRP
- DOI: 10.1182/blood-2021-147733
- Subjects: CICLOSPORINAS; ANEMIA
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2021
- Source:
- Conference titles: ASH Annual Meeting Abstracts
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
VALLEJO, Carlos et al. Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-147733. Acesso em: 27 dez. 2025. , 2021 -
APA
Vallejo, C., Jang, J. H., Finelli, C., Montaño Figueroa, E., Norasetthada, L., Calado, R. T., et al. (2021). Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-147733 -
NLM
Vallejo C, Jang JH, Finelli C, Montaño Figueroa E, Norasetthada L, Calado RT, Turgut M, Peffault de Latour R, Kriemler-Krahn U, Haenig J, Maier J, Scheinberg P. Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study [Internet]. Blood. 2021 ; 138 2174-2175.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1182/blood-2021-147733 -
Vancouver
Vallejo C, Jang JH, Finelli C, Montaño Figueroa E, Norasetthada L, Calado RT, Turgut M, Peffault de Latour R, Kriemler-Krahn U, Haenig J, Maier J, Scheinberg P. Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study [Internet]. Blood. 2021 ; 138 2174-2175.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1182/blood-2021-147733 - Androgen treatment mitigates hematopoietic cell telomere attrition in vivo
- Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation
- Telomeres in disease
- Células reprogramadas. [Depoimento a Hérika Dias e Luis Ribeiro]
- Telomere shortening in hepatocyte proliferation and predisposition to alcohol-induced steatosis
- A novel homozygous RTEL1 variant in a consanguineous Lebanese family: phenotypic heterogeneity and disease anticipation
- GATA2 mutation in long stand Mycobacterium kansasii infection, myelodysplasia and MonoMAC syndrome: a case-report
- BCL2A1a over-expression in murine hematopoietic stem and progenitor cells decreases apoptosis and results in hematopoietic transformation
- Molecular characterization of clinical response and relapse in patients with IDH1m ND-AML treated with Ivo+AZA in the aGILE study
- Targeting complement to treat paroxysmal nocturnal hemoglobinuria (PNH)
Informações sobre o DOI: 10.1182/blood-2021-147733 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003232353.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
